Press Releases

Apple's Key Supplier Foxconn's Gross Profit Hit 7 Year High In Q3, Aims To Expand AI Capabilities By Next Year
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
Ketamine Clinics Los Angeles Partners With FireflyVR For Virtual Reality-Enhanced Patient Care
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
Ketamine Clinics Los Angeles Partners With FireflyVR For Virtual Reality-Enhanced Patient Care
Post-Harvest Optimization Technology Consistently Produces Premium-Quality Cannabis, Studies Show
End Of Life Psychedelic Care Launches Directory Connecting Caregivers And Patients

Press Releases Recent News

SEC-Approved Cannabis Lender Acquired By Investment Giant, Changes Ticker To $LIEN
Chicago Atlantic acquires SEC-approved cannabis lender Silver Spike, renaming it Chicago Atlantic BDC. New ticker $LIEN effective October 2
Dow Surges To Fresh Highs As Major Indices Record Gains For 3rd Straight Week: Fear Index Remains In 'Greed' Zone
Nasdaq-Traded Cannabis Producer Bright Green Corporation Faces Delisting, Focuses On Strategic Growth
Bright Green Corporation addresses Nasdaq delisting, reinforces its commitment to shareholders, and outlines strategic partnerships and growth plans for the future.
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
Awakn Life Sciences expands its private placement to $2 million, closing the fourth tranche with $394,286 raised to accelerate research into addiction treatments.
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.
The Magnificent 7 'Unicorns': Startups That Dominate Private Investing
Private Magnificent 7 of U.S. companies in innovation space worth $382B, led by SpaceX, OpenAI, Stripe, Databricks, Fanatics, Scale AI, Rippling.
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
PharmAla Biotech partners with Johns Hopkins to supply MDMA for clinical trials, terminates contract with Red Light Holland, and presents new APA-01 research at the EBPS Workshop.
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disorder.
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI advancements in drug development.
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
Drug Science and UCL collaborate to refine MDMA-assisted therapy, addressing FDA concerns and enhancing psychotherapeutic practices for improved treatment outcomes.
Minnesota Nice Ethnobotanicals Launches, Largest In US Focused On Amanita Muscaria
Minnesota Nice Ethnobotanicals, the U.S.'s largest vertically integrated ethnobotanical company, offers plant-based wellness solutions.
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Avicanna secures a U.S. patent for its innovative deep penetrating topical cannabinoid composition for treating pain and inflammation.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved